Avidian Wealth Enterprises LLC Sells 712 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Avidian Wealth Enterprises LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.8% during the 4th quarter, Holdings Channel reports. The firm owned 2,410 shares of the healthcare conglomerate’s stock after selling 712 shares during the quarter. Avidian Wealth Enterprises LLC’s holdings in UnitedHealth Group were worth $1,219,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. M&T Bank Corp grew its position in UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its position in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. grew its position in UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC boosted its holdings in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $527.31 on Thursday. The company has a fifty day moving average of $526.25 and a two-hundred day moving average of $563.96. The stock has a market capitalization of $485.27 billion, a PE ratio of 34.02, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business earned $5.83 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.